HK1000469A1 - Vaccines - Google Patents

Vaccines

Info

Publication number
HK1000469A1
HK1000469A1 HK97101924A HK97101924A HK1000469A1 HK 1000469 A1 HK1000469 A1 HK 1000469A1 HK 97101924 A HK97101924 A HK 97101924A HK 97101924 A HK97101924 A HK 97101924A HK 1000469 A1 HK1000469 A1 HK 1000469A1
Authority
HK
Hong Kong
Prior art keywords
organisms
basis
vaccines
pathogens
vaccine
Prior art date
Application number
HK97101924A
Other languages
English (en)
Inventor
Dougan Gordon
Chatfield Steven Neville
Hormaeche Carlos Estenio
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of HK1000469A1 publication Critical patent/HK1000469A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK97101924A 1987-12-23 1997-10-15 Vaccines HK1000469A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878730037A GB8730037D0 (en) 1987-12-23 1987-12-23 Vaccines

Publications (1)

Publication Number Publication Date
HK1000469A1 true HK1000469A1 (en) 1998-03-27

Family

ID=10628973

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97101924A HK1000469A1 (en) 1987-12-23 1997-10-15 Vaccines

Country Status (21)

Country Link
EP (1) EP0322237B1 (de)
JP (1) JP2602970B2 (de)
KR (1) KR970010759B1 (de)
AT (1) ATE103331T1 (de)
AU (1) AU619519B2 (de)
BR (1) BR8807376A (de)
CA (1) CA1327331C (de)
DE (1) DE3888652T2 (de)
DK (1) DK174952B1 (de)
ES (1) ES2061700T3 (de)
GB (1) GB8730037D0 (de)
HK (1) HK1000469A1 (de)
HU (2) HUT55242A (de)
IE (1) IE65176B1 (de)
IL (1) IL88766A (de)
MY (1) MY104367A (de)
NZ (1) NZ227472A (de)
PH (1) PH31428A (de)
RU (1) RU2114172C1 (de)
WO (1) WO1989005856A1 (de)
ZA (1) ZA889605B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626139B2 (en) * 1989-01-12 1992-07-23 Commonwealth Scientific And Industrial Research Organisation Avirulent salmonella vaccine
IE61635B1 (en) * 1990-03-13 1994-11-16 Trinity College Dublin Improvements in vaccines
GB9007194D0 (en) * 1990-03-30 1990-05-30 Wellcome Found Live vaccines
CZ285118B6 (cs) * 1991-03-05 1999-05-12 The Wellcome Foundation Limited Exprese rekombinačních proteinů v oslabených bakteriích
TW201794B (de) * 1991-05-03 1993-03-11 American Cyanamid Co
EP0692031B1 (de) * 1993-02-22 2007-04-11 The General Hospital Corporation Heterologe antigene in stämmen zur impfung mit lebendzellen
US6036953A (en) * 1996-11-29 2000-03-14 The General Hospital Corporation Heterologous antigens in live cell V. cholerae strains
GB9711964D0 (en) * 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines
WO1999013053A1 (en) 1997-09-10 1999-03-18 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
EP0913480A3 (de) * 1997-11-03 2001-07-11 Smithkline Beecham Corporation Chorismat Synthase
US6905691B1 (en) 1997-12-11 2005-06-14 Celltech Pharma Europe Limited Vaccines containing attenuated bacteria
GB9806449D0 (en) 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
US6962696B1 (en) 1999-10-04 2005-11-08 Vion Pharmaceuticals Inc. Compositions and methods for tumor-targeted delivery of effector molecules
GB0121998D0 (en) 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
JP4623625B2 (ja) 2003-07-24 2011-02-02 株式会社ＡＭＢｉＳ ヘテロ型５量体組換えワクチン
FR2898276B1 (fr) * 2006-03-08 2008-07-25 Univ Claude Bernard Lyon Nouveaux vaccins destines au traitement ou a la prevention des infections par parasites de la famille des taenidae et en particulier du genre echinococcus
JP6145046B2 (ja) * 2010-12-22 2017-06-07 インターベット インターナショナル ベー． フェー． 全身投与用の生細菌単離株を含むワクチン
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337314A (en) * 1979-05-23 1982-06-29 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines

Also Published As

Publication number Publication date
AU619519B2 (en) 1992-01-30
KR970010759B1 (ko) 1997-06-30
HU216449B (hu) 1999-06-28
DK412689A (da) 1989-08-22
BR8807376A (pt) 1990-03-20
MY104367A (en) 1994-03-31
PH31428A (en) 1998-11-03
IE65176B1 (en) 1995-10-04
NZ227472A (en) 1992-07-28
ZA889605B (en) 1990-08-29
KR890010200A (ko) 1989-08-07
RU2114172C1 (ru) 1998-06-27
IL88766A (en) 1995-07-31
DK412689D0 (da) 1989-08-22
EP0322237B1 (de) 1994-03-23
HU890702D0 (en) 1991-01-28
JPH02502785A (ja) 1990-09-06
EP0322237A1 (de) 1989-06-28
HUT55242A (en) 1991-05-28
DE3888652T2 (de) 1994-07-07
ES2061700T3 (es) 1994-12-16
AU2919389A (en) 1989-07-19
CA1327331C (en) 1994-03-01
GB8730037D0 (en) 1988-02-03
IE883839L (en) 1989-06-23
ATE103331T1 (de) 1994-04-15
DK174952B1 (da) 2004-03-22
JP2602970B2 (ja) 1997-04-23
DE3888652D1 (de) 1994-04-28
WO1989005856A1 (en) 1989-06-29

Similar Documents

Publication Publication Date Title
GB8730037D0 (en) Vaccines
EP0020251A3 (en) Dna transfer vector, host transformed with it, vaccine, and their production
WO1980002504A1 (en) Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
AU2152988A (en) Intranasal vaccination of horses with inactivated microorganisms or antigenic material
IL74409A0 (en) Cloning of dna for protozoal antigens
DE3172477D1 (en) Group b streptococcal capsular polysaccharides
GR3034278T3 (en) Attenuated measles vaccine virus strain containing specific nucleotide sequence and a method for its absolute identification.
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
ZA796476B (en) Feline infectious peritonitis vaccine
ES466359A1 (es) Procedimiento para preparar vacunas vivas e inactivas del virus de la rabia.
OA09652A (en) Bioherbicide combining chemical agents and bacterial plant pathogens
IL67818A0 (en) Vaccines comprising ozone inactivated organisms and their production
DK145988A (da) Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse
DE2960853D1 (en) Intra-respiratory vaccine, modified bacteria strain used in it, vaccine dose form and process for preparing it
EP0415958A4 (en) A p1 bacteriophage cloning system for dna fragments as large as 95 kb
AU2713488A (en) Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20081221